World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
38662
World Ranking
17802
National Ranking
932

Overview

Olaf Witt is affiliated with the German Cancer Research Center in Germany. Their research is primarily situated at the intersection of medicine and biochemistry, genetics, and molecular biology, with a particular focus on genetics, molecular biology, neurology, cancer research, and oncology.

Their work encompasses a variety of topics, including:

  • Glioma Diagnosis and Treatment
  • Neuroblastoma Research and Treatments
  • Cancer Genomics and Diagnostics
  • Protein Degradation and Inhibitors
  • Cancer, Hypoxia, and Metabolism
  • Fibroblast Growth Factor Research
  • Epigenetics and DNA Methylation

Olaf Witt has contributed to several recent publications, notable among them:

  • Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials, 2020, published in The Lancet Oncology
  • Sarcoma classification by DNA methylation profiling, 2021, published in Nature Communications
  • Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes, 2020, published in Cancer Discovery
  • The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets, 2021, published in Cancer Discovery
  • Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group, 2020, published in The Lancet Oncology

The venues where Olaf Witt frequently publishes include:

  • Neuro-Oncology
  • Journal of Clinical Oncology
  • Cancer Research
  • Journal of Neuro-Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)

Frequent co-authors in their research network include:

  • Stefan M. Pfister
  • David Jones
  • Till Milde
  • Cornelis M. van Tilburg
  • Felix Sahm

Best Publications

  • DNA methylation-based classification of central nervous system tumours

    David Capper;David Capper;David Capper;David T. W. Jones;Martin Sill;Volker Hovestadt

  • Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

    Jeremy Schwartzentruber;Andrey Korshunov;Xiao Yang Liu;David T.W. Jones

  • Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

    Dominik Sturm;Hendrik Witt;Hendrik Witt;Volker Hovestadt;Dong Anh Khuong-Quang

  • The landscape of genomic alterations across childhood cancers

    Susanne N. Gröbner;Barbara C. Worst;Joachim Weischenfeldt;Joachim Weischenfeldt;Ivo Buchhalter

  • Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups

    Kristian W. Pajtler;Kristian W. Pajtler;Hendrik Witt;Martin Sill;David T.W. Jones

  • Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

    David Neal Franz;Elena Belousova;Steven Sparagana;E Martina Bebin

  • The whole-genome landscape of medulloblastoma subtypes

    Paul A. Northcott;Paul A. Northcott;Ivo Buchhalter;Ivo Buchhalter;A. Sorana Morrissy;Volker Hovestadt

  • Dissecting the genomic complexity underlying medulloblastoma

    David T. W. Jones;Natalie Jäger;Marcel Kool;Thomas Zichner

  • Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations

    Tobias Rausch;David T.W. Jones;Marc Zapatka;Adrian M. Stütz

  • Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade Gliomas

    Sebastian Bender;Sebastian Bender;Yujie Tang;Anders M. Lindroth;Volker Hovestadt

  • Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma

    David T W Jones;Barbara Hutter;Natalie Jäger;Andrey Korshunov;Andrey Korshunov

  • Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition

    Marcel Kool;David T.W. Jones;Natalie Jäger;Paul A. Northcott

  • Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials

    David S Hong;Steven G DuBois;Shivaani Kummar;Anna F Farago

  • Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma

    Paul A. Northcott;Catherine Lee;Catherine Lee;Thomas Zichner;Adrian M. Stütz

  • Epigenomic alterations define lethal CIMP-positive ependymomas of infancy

    S. C. Mack;H. Witt;R. M. Piro;L. Gu

  • Risk stratification of childhood medulloblastoma in the molecular era: the current consensus

    Vijay Ramaswamy;Marc Remke;Eric Bouffet;Simon Bailey

  • Delineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma

    Hendrik Witt;Stephen C. Mack;Marina Ryzhova;Sebastian Bender;Sebastian Bender

  • Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes

    Pascal D. Johann;Pascal D. Johann;Serap Erkek;Marc Zapatka;Kornelius Kerl

  • Histone Deacetylase 8 in Neuroblastoma Tumorigenesis

    Ina Oehme;Hedwig E. Deubzer;Dennis Wegener;Diana Pickert

  • Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing

    Volker Hovestadt;David T.W. Jones;Simone Picelli;Wei Wang

Frequent Co-Authors

Stefan M. Pfister
Stefan M. Pfister German Cancer Research Center
David T. W. Jones
David T. W. Jones German Cancer Research Center
Andreas von Deimling
Andreas von Deimling Heidelberg University
Michael D. Taylor
Michael D. Taylor University of Toronto
Marc Remke
Marc Remke German Cancer Research Center
Peter Lichter
Peter Lichter German Cancer Research Center
Marcel Kool
Marcel Kool German Cancer Research Center
Paul A. Northcott
Paul A. Northcott St. Jude Children's Research Hospital
Scott L. Pomeroy
Scott L. Pomeroy Boston Children's Hospital
Andreas E. Kulozik
Andreas E. Kulozik Heidelberg University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare but seeking flexible, alternative routes, online degrees offer valuable options. Whether you are just beginning your journey or aiming to advance your credentials, numerous accredited online programs cater to a wide range of needs and career goals.

Aspiring nurse practitioners can enroll in nurse practitioner programs to gain advanced clinical training and expand career opportunities. Those looking for a foundational degree can consider online nursing programs, which provide flexible options for earning a nursing credential without disrupting work or personal commitments.

Registered nurses hoping to take on leadership roles may benefit from phd in nursing online programs, designed to prepare future educators, researchers, and executives in healthcare. If you are already an RN seeking a bachelor's degree, consider the cheap rn to bsn programs for a cost-effective way to boost your qualifications and professional growth.

Exploring these affordable online degrees can help you find a flexible path toward healthcare advancement, even beyond traditional medical school.

Best Scientists Citing Olaf Witt

Trending Scientists

Recently Published Articles